AKU

Akumin Inc

Halal Rating :
Uncomfortable
Last Price $0
Market Cap $34.19m
1D Change

0.0 %

1 Year Change

0.0 %

Next Earnings Date

Yet to be announced

Company Overview

Akumin Inc. is a provider of outpatient diagnostic imaging services in the United States. The company offers a range of medical imaging services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other diagnostic and interventional radiology procedures.

Revenue Sources

Pass

Based on the review of Akumin's financial statements and business operations, the company generates its revenue primarily from medical imaging services and related healthcare activities. These services are considered halal as they provide essential healthcare diagnostics that benefit society. There is no evidence of revenue from prohibited sources such as alcohol, gambling, or other haram activities.

Reliance on Interest

Fail
Reporting Date Total Revenue Total Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2023 $180.62m $256.68m - $33.87m 0.00% 13.20%
June 30, 2023 $184.84m $280.48m - $31.16m 0.00% 11.11%
March 31, 2023 $187.59m $216.04m - $30.7m 0.00% 14.21%
Dec. 31, 2022 $184.63m $235.15m - $30.36m 0.00% 12.91%

The company's interest expenses relative to total expenses for the last four quarters were consistently high, averaging around 13-14% of total expenses. This indicates that interest plays a material role in the company's operations and financing structure. The high interest burden suggests significant reliance on interest-bearing debt.

Operational Ethics

Pass

Based on available information from SEC filings and company reports, there is no evidence of significant ongoing associations with entities involved in human rights violations such as the state of Israel or the Chinese Communist Party.

Rating Justification

Member Vote

Agree: 0 Disagree: 0

Login to vote on this

Comments

0 Comments

Login to join the discussion

Recent News & Updates